STOCK TITAN

Quest Diagnostics Teams Up with Two Health Systems to Deliver High-Value, Innovative Laboratory Services

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) announced collaborations with Montefiore Nyack Hospital and Goshen Hospital to enhance diagnostic services. The relationships will include management of hospital laboratories, supply chain management, and esoteric reference testing. Steve Rusckowski, CEO, highlighted the increasing demand from health systems for Quest's laboratory strategy support. As Quest serves a significant portion of the U.S. population, these partnerships aim to improve healthcare management and patient outcomes while addressing the challenges faced by hospitals.

Positive
  • New partnerships with Montefiore Nyack Hospital and Goshen Hospital to enhance diagnostic services.
  • Provision of laboratory management and supply chain management expertise.
  • Increased demand for Quest's laboratory strategy support from healthcare providers.
Negative
  • None.

SECAUCUS, N.J., Nov. 23, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced professional lab services relationships with two hospital health systems to enhance the quality and value of diagnostic services to patients and their doctors.

Quest will provide laboratory management services for Montefiore Nyack Hospital and its renal physician practice Highland Medical Rockland Renal Associates in Rockland County New York, including the day to day management of the hospital laboratories, laboratory supply chain management and esoteric reference testing.

Additionally, the company entered into a professional laboratory services relationship with Goshen Hospital, one of the top-rated hospitals in Indiana, to provide supply chain management expertise in addition to the reference testing which Quest currently provides. 

"We are pleased to team up with both of these outstanding health care providers," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics.  "In today's pressurized health care environment, health systems are increasingly turning to Quest for help executing in their lab strategy. Given the challenges that hospitals are facing, we expect many more to be open to discussions about how Quest can help them achieve their lab strategy." 

About Quest Diagnostics 
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-teams-up-with-two-health-systems-to-deliver-high-value-innovative-laboratory-services-301178164.html

SOURCE Quest Diagnostics

FAQ

What is Quest Diagnostics' recent announcement regarding health systems?

Quest Diagnostics announced partnerships with two health systems to enhance the quality and value of diagnostic services.

Which hospitals are partnering with Quest Diagnostics?

Quest Diagnostics is partnering with Montefiore Nyack Hospital and Goshen Hospital.

How will Quest Diagnostics support Montefiore Nyack Hospital?

Quest will provide laboratory management services and supply chain management at Montefiore Nyack Hospital.

What services will Quest provide to Goshen Hospital?

Quest will offer supply chain management expertise and reference testing services to Goshen Hospital.

When was the announcement made by Quest Diagnostics?

The announcement was made on November 23, 2020.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

16.99B
111.10M
0.43%
91.55%
2.32%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
SECAUCUS